Till BachmannReader in Personalised Medicine in Infectious Diseases University of Edinburgh
David SmithProfessor, Laboratory of Medicine & Pathology Mayo Clinic
Alexander NatzSecretary General EUCOPE
Personalised medicine. Arguably one of the most overused buzz phrases in the pharmaceutical industry. But with World CDx Frankfurt entering its 5th year and with biopharma, diagnostic companies and the ever growing plethora of genomic technology providers investing heavily in the space, precision medicine is becoming an ever closer reality.
World CDx Frankfurt is the premier networking, interactive and solution-led conference to overcome clinical biomarker, commercialisation, regulatory and reimbursement hurdles facing successful companion diagnostic development. Furthermore, the genomic revolution and advances in next generation sequencing are providing Rx/Dx partnerships with new toolkits to streamline co-development and bring precision therapies to market.
More cutting edge data, top level speakers and networking opportunities than any other meeting. And that’s not to mention some really exciting changes in 2014.
For an industry centred around collaboration, gone are the days of repetitive powerpoint presentations. The agenda has been designed to promote interaction and audience engagement, with multiple opportunities to network, interact and debate best practice via:
“This was a very useful meeting and I would recommend it highly. I liked the ability to share experiences and compare notes with others on the pharma & Dx industries. Very educational overall” Pfizer
“Expertise from thought leaders is rarely so freely given, or as earnestly debated.” CHI Center for Translational Research
Excellent networking opportunity with current and potential Co-Dx partners.” Dako
Excellent cross section of core science, regulatory, commercialisation and project management from both pharma and diagnostic companies. Very educational. Eli Lilly